Open AccessAssociation of Pharmacological Treatments for Obesity With Weight Loss and Adverse Events
Author(s) -
Rohan Khera,
M. Hassan Murad,
Apoorva K. Chandar,
Parambir S. Dulai,
Zhen Wang,
Larry J. Prokop,
Rohit Loomba,
Michael Camilleri,
Siddharth Singh
Publication year - 2016
Publication title -
jama
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.688
H-Index - 680
eISSN - 1538-3598
pISSN - 0098-7484
DOI - 10.1001/jama.2016.7602
Subject(s) - medicine , liraglutide , weight loss , adverse effect , orlistat , phentermine , placebo , discontinuation , randomized controlled trial , overweight , topiramate , odds ratio , body mass index , obesity , diabetes mellitus , type 2 diabetes , endocrinology , psychiatry , alternative medicine , pathology , epilepsy
Five medications have been approved for the management of obesity, but data on comparative effectiveness are limited.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom